Medicis Pharmaceutical (MRX) guides its Q4 lower, now saying that it expects revenues to be in...

|By:, SA News Editor

Medicis Pharmaceutical (MRX) guides its Q4 lower, now saying that it expects revenues to be in the range of $170M - $183M, down from its previous range of $187M - $200M and below Street estimates of $190M. The company also said that it expects a decrease in its EPS to a range of $0.51 - $0.57. The company attributes the lowered numbers to expenses related to the implementation of new strategic initiatives. Shares -3.8% AH.